Shiba, Shintaro
Shimo, Takahiro
Yamanaka, Masashi
Matsumoto, Kazuki
Yamano, Akihiro
Nitta, Kazunori
Sakai, Makoto
Ohno, Tatsuya
Tokuuye, Koichi
Omura, Motoko
Article History
Received: 7 May 2025
Accepted: 8 July 2025
First Online: 15 July 2025
Declarations
:
: Not applicable as this study was an in vitro experiments using only commercially available cell lines and did not use any patient-related information.
: Not applicable.
: Boronophenylalanine was provided by Stella Pharma Corporation (Japan). Tatsuya Ohno received funding from Hitachi. The authors declare no conflict of interest.
: Boronophenylalanine was provided by Stella Pharma Corporation (Japan). Tatsuya Ohno received funding from Hitachi. The authors declare no conflict of interest.
: This study received no external funding.